Condition: Stroke · Sponsor: University Hospital, Grenoble
The clinical investigation will take place in three phases: * A pre-selection/selection phase to ensure that the patient (lesion, symptoms, ability of our tools to detect your movement intentions, etc.) is suitable for a six-month intensive rehabilitation program using Brain-Machine Interface. * A second phase, consisting of implementing the intensive rehabilitation program, first in the traditional manner, without the Brain-Machine Interface (2 to 5 weeks), then, after implantation, with the Brain-Machine Interface (6 months). * During the third phase, only follow-up visits will be scheduled to ensure the longevity of the implants and the maintenance of the motor progress achieved through rehabilitation.
This description comes directly from the study's public registry record.
Olivier DETANTE, MD, PhD · 04 76 76 57 89 · ODetante@chu-grenoble.fr
Caroline SANDRE-BALLESTER, PhD · 0438782851 · csandreballester@chu-grenoble.fr
Always discuss trial participation with your own doctor first.
| CHUGA | Grenoble, France | Recruiting |
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.